Cargando…

SUN-618 Decision Analysis for Glucagon-Like Peptide Receptor Agonists vs. Sodium-Glucose cotransporter2 Inhibitors in Type 2 Diabetes Mellitus

Background: Cardiovascular outcome trials (CVOT) of glucagon-like peptide-1receptor agonists (GLP-1 RA) and sodium-glucose co-transporter 2 inhibitors (SGLT2i) demonstrated reduction of major adverse cardiovascular events (MACE), cardiovascular deaths (CVD), and renal outcomes (RO). Objective. Evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	khazaali, Ali Al, Mckee, Alexis, Sharma, Anjul, Albert, Stewart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208632/ http://dx.doi.org/10.1210/jendso/bvaa046.860

Ejemplares similares

SUN-188 Contributing Factors Precipitation Diabetic Ketoacidosis in Patients Using Sodium-Glucose Cotransporter-2 Inhibitor
por: Attia, Jonven, et al.
Publicado: (2019)

SUN-LB032 Severe Insulin Resistance and Nephrotic Range Proteinuria Reversed by Pioglitazone in a Patient With Dunnigan Type Lipodystrophy
por: Sharma, Anjul, et al.
Publicado: (2019)

SUN-164 Use of Metformin, Premixed Insulin, and Glucagon-Like Peptide-1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes Mellitus
por: Fazeli, Sasan, et al.
Publicado: (2019)

MON-LB032 Real World Evidence Data on the Role of Sodium/Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonist in Chronic Kidney Disease Stage 3 Patients beyond Glycemic Control, at Glycemia Clinic- Kuwait
por: Shaghouli, Amna, et al.
Publicado: (2019)

Effects of Sodium Glucose Cotransporter 2 Inhibitor on Renal Renin-Angiotensin-Aldsoterone System
por: Takeda, Yoshiyu, et al.
Publicado: (2021)

SAT-618 Nattokinase to Improve Insulin Sensitivity and Weight Loss in Women with Obesity +/- Diabetes
por: Cobos, Leopoldo M, et al.
Publicado: (2020)

Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
por: Quadri, Hamza, et al.
Publicado: (2021)

A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes
por: Sato, Tetsuhiko, et al.
Publicado: (2021)

Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM
por: McKee, Alexis, et al.
Publicado: (2020)

SUN-150 Complications of DKA in Teaching Vs. Non-Teaching Hospitals
por: Motlaghzadeh, Yasaman, et al.
Publicado: (2019)

MON-618 A Framework for Understanding and Managing ‘The Diabetes Syndrome’: A Unified Pathophysiologic Approaching the Context of the Beta-Cell Classification of Diabetes
por: Schwartz, Stanley S
Publicado: (2020)

SUN-673 Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor
por: Narang, Disha K, et al.
Publicado: (2020)

SUN-149 Cardiologist vs. Endocrinologist Encounters in Patients with T2D and CVD: Potential Implications for Glucose-Lowering Therapy Use and Education
por: Gunawan, Felona, et al.
Publicado: (2019)

THU338 Risks Of Stroke, Its Subtypes And Atrial Fibrillation Associated With Glucagon-like Peptide 1 Receptor Agonists Versus Sodium-glucose Cotransporter 2 Inhibitors: A Real-world Population-based Study In Hong Kong
por: Lui, David, et al.
Publicado: (2023)

SUN-664 Effects of Acute Hyperglycemia on Monocytes in Type 2 Diabetes
por: Zhang, Rong Mei, et al.
Publicado: (2020)

SUN-686 Diabetic Retinopathy in Latinos with Type 2 Diabetes: Temperance Is Protective
por: Fukunaga, Alex, et al.
Publicado: (2020)

SUN-654 Dynamic and Regional Variation of Pancreatic Innervation in Diabetes
por: Alvarsson, Alexandra, et al.
Publicado: (2020)

SUN-684 The Dance of Diabetes
por: Thakkar, Aditi, et al.
Publicado: (2020)

SUN-696 Effect of Night Shifts on Glycemic Variability in Patients with Type 2 Diabetes
por: Garieva, Mayya Akakievna
Publicado: (2020)

SUN-668 Elevated Osmolal Gap in Long-Term Complication of Type 2 Diabetes
por: Klimek, Monika, et al.
Publicado: (2020)

SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients
por: Singh, Priyamvada, et al.
Publicado: (2019)

Scientific and Regulatory Considerations for the Approval of the First Generic Glucagon
por: Pang, Eric, et al.
Publicado: (2021)

SUN-651 Murine Cecal Ligation and Puncture (CLP) Perturbs Phosphorylation of Insulin Receptor Substrate 2 (IRS-2)
por: Mathew, Deepa, et al.
Publicado: (2020)

SUN-177 House Of Carbs: The Path To Euglycemic Dka In Patients With Diabetes On Sglt2 Inhibitors
por: Islam, Julie, et al.
Publicado: (2019)

SUN-145 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2019)

SUN-691 Type 2 Diabetes Management in the Context of Smith-Magenis Syndrome: Case Report
por: Mulvaney, Kylie Tamm, et al.
Publicado: (2020)

SUN-182 When Insulin Is Not Enough...
por: DiCenso, Daniela, et al.
Publicado: (2019)

SUN-187 Dolutegravir Causing Diabetes
por: Kamal, Palwasha, et al.
Publicado: (2019)

SUN-185 Glipizide Induced Hepatotoxicity
por: Kamal, Palwasha, et al.
Publicado: (2019)

FRI618 Lifetime Risk Of Nontraumatic Lower-extremity Amputation
por: Ding, Ning, et al.
Publicado: (2023)

SUN-LB114 Remission of Type 2 Diabetes (DMT2) in Hypogonadal Men Under Long-Term Testosterone Therapy
por: Mskhalaya, George, et al.
Publicado: (2020)

SUN-689 Treatment of Hepatitis C Has Time-Dependent Relationship with Type 2 Diabetes Progress
por: Liu, Luna, et al.
Publicado: (2020)

SUN-688 Pancreatic Cancer in Longstanding Diabetes
por: Suarez, Janine
Publicado: (2020)

SUN-683 Was Metformin the Culprit for This Lactic Acidosis?
por: Vemparala, Pranathi, et al.
Publicado: (2020)

SUN-157 Clinical and Demographic Profile of Type 2 Diabetes Patients: an Epidemiology Report from Central India
por: Dash, Kalpana, et al.
Publicado: (2019)

SUN-147 Sarcopenia Is Associated with the Degree of Insulin Resistance and Risk of Type 2 Diabetes in Older Age Group
por: Son, Jang Won, et al.
Publicado: (2019)

SUN-693 What Else Should Be Done in Patients with Uncontrolled Type 2 Diabetes and Severe Insulin Allergy?
por: Elshimy, Ghada, et al.
Publicado: (2020)

SUN-184 Sertraline-Induced Hypoglycemia in Nondiabetic Patients
por: Bhargava, Pooja, et al.
Publicado: (2019)

SUN-171 Glargine Use in a Neonatal Diabetic
por: Sandhu, Sanjeet, et al.
Publicado: (2019)

SUN-179 Prolonged Hypoglycemia from Insulin Degludec
por: Kothari, Vallari, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sg4cl832hgh6k7814f40f3nl42